Leukemia

Clinical trial delivers good results in leukemia patients

Huntsman Cancer Institute (HCI) researchers Michael Deininger, M.D., Ph.D., and Thomas O'Hare, Ph.D., were part of a team that found a potent oral drug, ponatinib, effective in patients who have developed resistance to standard ...

Nov 30, 2012
popularity not rated yet | comments 0

A code of silence in acute myeloid leukemia

The development of acute myeloid leukemia (AML) is associated with a variety of genetic changes. Some of these alterations are epigenetic, wherein the sequence of the genes is unchanged, but chemical modifications to the ...

Nov 19, 2012
popularity 5 / 5 (1) | comments 0

Synribo approved to treat rare leukemia

(HealthDay)—Synribo (omacetaxine mepesuccinate) has been approved by the U.S. Food and Drug Administration to treat a rare blood and bone marrow disease called chronic myelogenous leukemia (CML).

Oct 26, 2012
popularity not rated yet | comments 0

Latest Spotlight News

Schizophrenic brains take indirect paths

Analysis of the structural connectivity in the brains of 16 schizophrenia patients reveals several zones affected by the disease and their reduced network connectivity.

New drugs from fish oil could aid artery repair

Every year, more than a half-million Americans undergo procedures to have a narrowed coronary artery propped open with a small metal mesh tube, or stent. The procedure is common for certain patients who've ...